The Alliance for Recovery-Centered Addiction Health Services, of which the AHA is a member, today announced an alternative payment model designed to provide patients a long-term, comprehensive and integrated pathway to addiction treatment and recovery. The Addiction Recovery Medical Home model – which incorporates bundled payments, quality targets and shared-savings – promotes improved integration of treatment and recovery resources. It sets forth corresponding financial incentives that benefit all stakeholders when the patient is well managed by a multi-disciplinary care team, the Alliance said. AHA and its hospital and health system members worked closely with the Alliance to design the model. “Designing a new payment and care delivery model is no small task and required a lot of work and collaboration,” said Joanna Hiatt Kim, AHA vice president of payment policy, at an event in Washington, D.C. today announcing the model. “We are thrilled that it is now public so that the most important work – the work to help our patients and our communities – can begin.” The Alliance intends to pilot the ARMH model in at least two markets beginning in 2019. For more information on the Alliance’s work and members, which also include Intermountain Healthcare, visit incentivizerecovery.org.

Related News Articles

Press Releases
Guides/Reports
Public
A new AHA report highlights some of the significant changes and future challenges that impact hospitals and health systems.
Press Releases
AHA Center for Health Innovation Market Scan
All of health care is undergoing rapid transformation as organizations accelerate innovation efforts, explore partnership opportunities and other options for…
AHA Center for Health Innovation Market Scan
All of health care is undergoing rapid transformation as organizations accelerate innovation efforts, explore partnership opportunities and other options to…
Special Bulletin
Member
The Department of Health and Human Services today issued a final rule making Jan. 1 the effective date of its final regulations on drug ceiling prices and…